Search Results 421-430 of 17413 for bisphosphonates side effects

  1. Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study - Mayo Clinic

    ... side effects. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  2. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... The purpose of this study is to estimate the rate of sustained MRD negativity (MRD negative ... * NOTE: ...

  3. Osteoporosis - Doctors and departments - Mayo Clinic

    Fractures associated with this bone-weakening condition can be life altering. Good nutrition, regular exercise and medicines can help.

  4. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    The purpose of this study is to test the safety, side effects, and best dose of ASTX727 when given together with paclitaxel and pembrolizumab in patients ...

  5. Spina bifida - Symptoms and causes - Mayo Clinic

    Learn about this condition in which an unborn baby's spine and spinal cord don't form properly. Surgery during pregnancy may be a treatment option.

  6. If your blood pressure medicine is causing sexual side effects, talk with your healthcare professional about your options. Some high blood pressure ...

  7. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... Negative pregnancy test done ≤7 days prior to ... Note: Bisphosphonates are supportive care rather ...

  8. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  9. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... HER2 is negative if a single test (or all tests) ... Concurrent bisphosphonate therapy is allowed.

  10. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    About this study. This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with ...